We found that the B-cell lymphoma 2 (Bcl-2)/Bcl-2 X-associated (Bax) ratio was significantly higher in the BPH group than in the control group, while it was significantly lower in the Igsu group than in the BPH group. The gene discussed is BCL2; the disease is benign prostatic hyperplasia.